共 74 条
[11]
Vitre P(2019)A comparison of national guidelines for network meta-analysis Value Health. 22 1178-S410
[12]
Osinska B(2019)HT2 Is there potential for joint health technology assessment (HTA) in Europe? An evaluation of EUnetHTA joint clinical assessments vs. national appraisals in oncology Value in Health. 22 S409-463
[13]
Allen N(2018)Is the EUnetHTA HTA Core Model® fit for purpose? Evaluation from an industry perspective Int. J. Technol. Assess. Health Care 34 458-606
[14]
Liberti L(2013)A tutorial on sensitivity analyses in clinical trials: the what, why, when and how BMC Med. Res. Methodol. 13 92-undefined
[15]
Walker SR(2019)PNS18 Shaping the future of European health technology assessments: Establishing a European PICO Value in Health. 22 S798-undefined
[16]
Salek S(2018)Confirmatory versus explorative endpoint analysis: decision-making on the basis of evidence available from market authorization and early benefit assessment for oncology drugs Health Policy 122 599-undefined
[17]
Chassagnol F(undefined)undefined undefined undefined undefined-undefined
[18]
Marcelli G(undefined)undefined undefined undefined undefined-undefined
[19]
Wagle J(undefined)undefined undefined undefined undefined-undefined
[20]
Giuliani G(undefined)undefined undefined undefined undefined-undefined